Researchers Identify a Possible Immune-Related Trigger for Some Preterm Births

Preterm birth occurs when a baby is born before 37 completed weeks of pregnancy. It is an important cause of newborn illness and death because premature babies may have underdeveloped lungs, feeding difficulties, problems regulating body temperature and a greater risk of complications affecting multiple organs.

Inflammation is part of the body's normal immune response, but excessive or poorly controlled inflammation can affect pregnancy. The reported research examined antibodies that neutralise interleukin-1 receptor antagonist (IL-1RA), a protein that normally limits signalling by the inflammatory molecule IL-1 beta.

Researchers found higher levels of these antibodies early in some pregnancies that later ended in preterm birth. In mouse experiments, introducing the antibodies increased inflammatory signalling and caused placental damage. The findings suggest a possible mechanism for a subset of preterm births rather than a universal explanation.

Further research is needed to confirm how frequently this mechanism occurs, how reliably it can be detected and whether interventions targeting the pathway can prevent early labour. The study does not establish that an existing anti-inflammatory medicine can safely prevent preterm birth.

Pregnant patients should attend routine prenatal care and discuss symptoms such as contractions, fluid leakage or bleeding promptly with their maternity-care team.